These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11678078)

  • 1. [The portrait of Dorian Gray, who? me?].
    Detrés LL
    Sidahora; 2001; ():22-3. PubMed ID: 11678078
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-HIV agents. Leading to lipodystrophy.
    TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Improvement of lipodystrophy associated with protease inhibitors].
    Boll Chim Farm; 1999 Apr; 138(4):192-3. PubMed ID: 10422331
    [No Abstract]   [Full Text] [Related]  

  • 4. Side effects. Protease inhibitors and loss of fat.
    TreatmentUpdate; 2000 Aug; 12(5):1-2. PubMed ID: 12125604
    [No Abstract]   [Full Text] [Related]  

  • 5. Protease inhibitors raising quality-of-life issues for HIV patients.
    Silversides A
    CMAJ; 1999 Mar; 160(6):894. PubMed ID: 10189444
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipodystrophy--introduction.
    TreatmentUpdate; 2001; 13(7):2-3. PubMed ID: 11794857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peripheral lipodystrophy associated with protease inhibitor therapy].
    Cabot de Vega E; Fontecha Gómez BJ; Solé Arnau R; Pedrol Clotet E
    Rev Clin Esp; 1999 Aug; 199(8):546-7. PubMed ID: 10522441
    [No Abstract]   [Full Text] [Related]  

  • 8. Focus on fat.
    TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipodystrophy and women: a beach ball on sticks.
    Marcotte B
    Posit Aware; 2004; 15(3):14-6. PubMed ID: 15206387
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease inhibitors in HIV infection. Lipodystrophy may be a consequence of prolonged survival.
    Buss N; Duff F
    BMJ; 1999 Jan; 318(7176):122. PubMed ID: 9880292
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxicity of antiretroviral therapy and implications for drug development.
    Carr A
    Nat Rev Drug Discov; 2003 Aug; 2(8):624-34. PubMed ID: 12904812
    [No Abstract]   [Full Text] [Related]  

  • 12. A nuke-free regimen.
    TreatmentUpdate; 2003; 15(2):7-8. PubMed ID: 12693364
    [No Abstract]   [Full Text] [Related]  

  • 13. Damage to the power plant.
    TreatmentUpdate; 2002 Mar; 14(3):1-2. PubMed ID: 12033185
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipodystrophy in HIV-1-infected patients.
    Mercié P; Tchamgoué S; Dabis F; Pellegrin JL
    Lancet; 1999 Sep; 354(9181):867-8. PubMed ID: 10485755
    [No Abstract]   [Full Text] [Related]  

  • 15. The latest word on lipodystrophy and mitochondrial toxicity (and old words that still resound).
    Mascolini M
    IAPAC Mon; 2002 Jan; 8(1):14-32. PubMed ID: 11858198
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipodystrophy in HIV-1-infected patients.
    Domingo P; Pérez A; Torres OH; Montiel JA; Vázquez G
    Lancet; 1999 Sep; 354(9181):868. PubMed ID: 10485756
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse drug reactions to protease inhibitors.
    Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ
    Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution for protease inhibitors in HIV therapy.
    Mikhail E
    N Engl J Med; 2003 Dec; 349(25):2460-1; author reply 2460-1. PubMed ID: 14689602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Facial lipodystrophy in patients with HIV infections troublesome to treat].
    Walther RA
    Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of HIV-associated lipodystrophy.
    Wanke C
    AIDS Clin Care; 2000 Dec; 12(12):100. PubMed ID: 12211161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.